Nanotechnology Now - Press Release: Aspen Aerogels, Inc. Announces Launch of Initial Public Offering

Home > Press > Aspen Aerogels, Inc. Announces Launch of Initial Public Offering

Abstract:
Aspen Aerogels, Inc. ("Aspen Aerogels") announced today that it has commenced an initial public offering of 6,666,667 shares of common stock pursuant to a registration statement filed with the U.S. Securities and Exchange Commission (the "SEC"). The initial public offering price is currently expected to be between $14.00 and $16.00 per share. Aspen Aerogels intends to grant the underwriters an option to purchase up to an additional 1,000,000 shares of common stock at the initial public offering price less the underwriting discount, within 30 days from the date of the offering. An application has been made to list the common stock of Aspen Aerogels on the New York Stock Exchange under the symbol "ASPN."

Aspen Aerogels, Inc. Announces Launch of Initial Public Offering

Northborough, MA | Posted on June 2nd, 2014

Aspen Aerogels intends to use the net proceeds from this proposed offering to fund additional expenditure for its third production line at its facility in East Providence, R.I., for repayment of amounts outstanding under its revolving line of credit and subordinated notes, and for general corporate purposes, which will include funding a portion of the design, development and construction of its planned second production plant in Europe or Asia after completion of its third production line at its facility in East Providence, R.I.

Barclays, J.P. Morgan, and Citigroup are acting as joint book-running managers of the proposed offering. Baird and Canaccord Genuity are acting as co-managers of the proposed offering.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

The proposed offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus related to the offering may be obtained from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at: , or by telephone: (888) 603-5847; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by calling tolling-free at 1-866-803-9204; and Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146).

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

####

About Aspen Aerogels, Inc.
Aspen Aerogels is an energy technology company that designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in large-scale energy infrastructure facilities. Headquartered in Northborough, Mass., Aspen Aerogels manufactures its Cryogel®, Pyrogel® and Spaceloft® products at its facility in East Providence, R.I.

Special Note Regarding Forward-Looking and Cautionary Statements

This press release contains forward-looking statements including statements relating to the proposed initial public offering. These statements are not historical facts but rather are based on Aspen Aerogels' current expectations, estimates and projections regarding Aspen Aerogels' business, operations and other factors relating thereto, including with respect to the proposed initial public offering. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates" and similar expressions are used to identify these forward-looking statements. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Aspen Aerogels' filings with the SEC.

For more information, please click here

Contacts:
Susan White
508-691-1143

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: